Bone and Cancer
Bone and Cancer
Bone and CancerBone and Cancer Foundation, PO Box 287452 Bone and Cancer New York, NY 10128-0025  
Toll Free: 888 862-0999 Bone and Cancer Email:  
Bone and Cancer

Clinical Trials

Photodynamic Therapy

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.


Approval Status:

Approved January, 1996

Specific Treatments:

esophageal cancer

Therapeutic Areas

General Information

Photodynamic Therapy (PDT) utilizes the light-activated drug, Photofrin, in combination with laser light of a specific wavelength and fiberoptic delivery devices to kill cancerous cells selectively with minimal side effects. The approval of PDT's laser system came in conjunction with the FDA approval of Photofrin to treat esophageal cancer.

 How To Order Publications:

Information About

Clinical Trials



















  Copyright 2011 - The Bone and Cancer Foundation